Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.75 EUR
309.70 M EUR
2.78 B EUR
25.69 M
About SARTORIUS STED BIO
Sector
Industry
CEO
René Fáber
Website
Headquarters
Aubagne
Founded
1978
ISIN
FR0013154002
FIGI
BBG00CVVGPD3
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RG8 is 171.85 EUR — it has decreased by −4.14% in the past 24 hours. Watch SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stocks are traded under the ticker 0RG8.
0RG8 stock has fallen by −4.88% compared to the previous week, the month change is a −1.49% fall, over the last year SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) has showed a −14.17% decrease.
We've gathered analysts' opinions on SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) future price: according to them, 0RG8 price has a max estimate of 310.00 EUR and a min estimate of 134.00 EUR. Watch 0RG8 chart and read a more detailed SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock forecast: see what analysts think of SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) and suggest that you do with its stocks.
0RG8 reached its all-time high on Sep 10, 2021 with the price of 550.00 EUR, and its all-time low was 50.75 EUR and was reached on Oct 17, 2017. View more price dynamics on 0RG8 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RG8 stock is 6.69% volatile and has beta coefficient of 1.25. Track SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock price on the chart and check out the list of the most volatile stocks — is SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) there?
Today SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) has the market capitalization of 17.86 B, it has increased by 2.01% over the last week.
Yes, you can track SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financials in yearly and quarterly reports right on TradingView.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
0RG8 earnings for the last quarter are 0.76 EUR per share, whereas the estimation was 0.80 EUR resulting in a −4.68% surprise. The estimated earnings for the next quarter are 0.97 EUR per share. See more details about SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) earnings.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) revenue for the last quarter amounts to 655.40 M EUR, despite the estimated figure of 685.76 M EUR. In the next quarter, revenue is expected to reach 710.61 M EUR.
0RG8 net income for the last quarter is 25.50 M EUR, while the quarter before that showed 47.60 M EUR of net income which accounts for −46.43% change. Track more SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financial stats to get the full picture.
Yes, 0RG8 dividends are paid annually. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 0.38%. Tracking SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) dividends might help you take more informed decisions.
SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) dividend yield was 0.29% in 2023, and payout ratio reached 20.53%. The year before the numbers were 0.48% and 15.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 10.66 K employees. See our rating of the largest employees — is SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) EBITDA is 637.60 M EUR, and current EBITDA margin is 26.02%. See more stats in SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financial statements.
Like other stocks, 0RG8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) stock shows the strong sell signal. See more of SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.